5 Best Low Risk Stocks to Buy in 2023

Page 5 of 5

1. Merck & Co., Inc. (NYSE:MRK)

Number of Hedge Fund Holders: 78

Beta Value: 0.37

Merck & Co., Inc. (NYSE:MRK) is a biopharmaceutical company with a focus on delivering solutions for oncology, vaccines, infectious diseases, Cardio-metabolic disorders, and Discovery & development. Its product pipeline comprises 83 programs in Phase 2, 30 programs in Phase 3, and 3 programs Under Review, including COVID19 vaccines.

On November 9, Deutsche Bank analyst James Shin initiated coverage of Merck & Co., Inc. (NYSE:MRK) shares with a target price of $115 with a ‘Buy’ rating for the stock. Earlier in November, the company announced that it had received FDA approval for KEYTRUDA, in combination with gemcitabine and cisplatin, for the treatment of patients with locally advanced unresectable or metastatic biliary tract cancer.

Merck & Co., Inc. (NYSE:MRK) is the best low risk stock to buy in 2023 based on hedge fund sentiment and low beta value according to the methodology used by us for preparing this list. Its shares were held by 78 hedge funds with total value of $2.7 billion, as of June 30. Cliff Asness’ AQR Capital Management was the largest hedge fund shareholder with ownership of 2.9 million shares valued at $332 million.

You may also like to read Top 11 Extreme Value Stocks To Buy and 11 Best S&P 500 Stocks To Buy According to Ray Dalio’s Bridgewater Associates

Page 5 of 5